Utility of DFI-EUS for differential diagnosis in pancreatic tumors.

Utility of DFI-EUS for differential diagnosis in pancreatic tumors. - DFI-EUS for pancreatic tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039581

Enrollment

450

Registered

2021-01-01

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed or suspected pancreatic lesion with imaging modalities

Exclusion criteria

Exclusion criteria: Patients who could not undergo EUS

Design outcomes

Primary

Measure	Time frame
To evaluate the utility of DFI-EUS for the differential diagnosis of pancreatic tumors	—

Countries

Japan

Contacts

Public ContactYamashita Yasunobu

Wakayama Medical University Second Department of Internal Medicine

yasunobu@wakayama-med.ac.jp073-447-2300

Outcome results